NORMAL SITUATION

PSY PLURIEL

Financial year 2026 · closed on 30/04/2026
Net result
-4,3 k €
-62.5% YoY
Gross margin
-4,3 k €
-133.8% YoY
Equity
-129,8 €
-103.1% YoY

Company — Normal situation.

Strike-off: 04 juin 2026

What does PSY PLURIEL do?

PSY PLURIEL is a Private company with limited liability incorporated in 2008.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0895.488.459
Incorporation
05/02/2008
Legal form
Private company with limited liability
Contributed capital
18 600,00 €
Latest accounts
30/04/2026
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 5 financial years

20262025202420232022
Income statement
Gross margin-4,3 k €-1,8 k €-15,5 k €6,2 k €10 k €
EBITDA-4,3 k €-2,4 k €-15,9 k €5,8 k €9,7 k €
Operating result-4,3 k €-2,4 k €-15,9 k €5,8 k €9,6 k €
Net result-4,3 k €-2,6 k €-16,2 k €3,9 k €35,8 k €
Balance sheet
Equity-129,8 €4,2 k €6,8 k €23 k €19,1 k €
Total assets4,9 k €8,2 k €25,8 k €34,9 k €
Cash4,6 k €7,7 k €20,8 k €21 k €
Debts129,8 €689,4 €1,4 k €2,8 k €15,7 k €
Governance

Board of directors

Seen on filing of 30/04/2026 · 2 active · 2 ended

Active mandates

alphapsy

Mandate · 0894.085.424

Represented by Laurent VICTOOR

Active
CABINET MEDICAL DANIEL SOUERY

Mandate · 0895.028.797

Represented by Daniel SOUERY

Active

Ended mandates

alphapsy

Director · 0894.085.424

Represented by Laurent VICTOOR

Ended
CABINET MEDICAL DANIEL SOUERY

Director · 0895.028.797

Represented by Daniel SOUERY

Ended
Annual accounts

Full financial information

20262025202420232022
Type of accountMicro modelAbridged modelMicro modelAbridged modelAbridged model
Start of the financial year01/01/202601/01/202501/01/202401/01/202301/01/2022
Closing of the financial year30/04/202631/12/202531/12/202431/12/202331/12/2022
Length of the financial year4 months12 months12 months12 months12 months
Filing date10/09/202609/02/202614/06/202510/03/202401/08/2023
General meeting30/04/202606/02/202612/06/202504/03/202412/06/2023
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

5 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/04/202630/04/202610/09/2026FrenchPDF
Abridged model31/12/202506/02/202609/02/2026FrenchPDF
Micro model31/12/202412/06/202514/06/2025FrenchPDF
Abridged model31/12/202304/03/202410/03/2024FrenchPDF
Abridged model31/12/202212/06/202301/08/2023FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/04/2026 · 2 active · 2 ended

Active mandates

alphapsy

Mandate · 0894.085.424

Represented by Laurent VICTOOR

Active
CABINET MEDICAL DANIEL SOUERY

Mandate · 0895.028.797

Represented by Daniel SOUERY

Active

Ended mandates

alphapsy

Director · 0894.085.424

Represented by Laurent VICTOOR

Ended
CABINET MEDICAL DANIEL SOUERY

Director · 0895.028.797

Represented by Daniel SOUERY

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Dissolution10/06/2026
    RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2026
    Annual accounts 2026-4,3 k €
  2. 2025
    Annual accounts 2025-2,6 k €
  3. 2024
    Annual accounts 2024-16,2 k €
  4. 2023
    Annual accounts 20233,9 k €
  5. 2022
    Annual accounts 202235,8 k €
  6. 05/02/2008
    IncorporationPrivate company with limited liability